Abstract:Objective:To analyze the incidence of complications in different stage patients with diabetic nephropathy (DN). Methodology:Seven hundred and seventy four patients with clinical or biopsy-proven 2 type DN were enrolled. They were divided into microalbuminuria (n=210),proteinuria (n=246) and renal dysfunction group (n=318) according to the level of urine protein and serum creatinine. We calculated the complication incidence in patients in different stage and compared the difference of their metabolic parameters. Results:The mean age of these patients was (56.6±11.3) years old,and the median duration of diabetes mellitus was 96 months,and 12 months for DN. Hypertension presented in 80.6% patients with DN,most of whom with impaired renal function. Retinopathy was gradually increasing with the progression of DN. The prevalence of retinopathy in patients with impaired renal function was statistically higher than that in patients with normal renal function. The incidence of peripheral neuropathy was 49.5%,most of which was superficial sensation disorder. Gastrointestinal dysfunction and impotence were predominant in autonomic neuropathy. The neuropathy occurred in majority of patients with impaired renal function. The difference of prevalence of angina and myocardial infarct wasn't distinguished among the patients in different stages. Myocardium ischemia was more common in patients with elevated serum creatinine,counting for 40.3%. Myocardium diastolic function decreased with the development of DN. Cerebral ischemia was predominant in cerebral vessels diseases. Diabetic foot was scarce in these patients. The prevalence of intermittent claudication was 7.5 percent. The qualification rate of glycosylated hemoglobin was higher in microalbuminuria group than those in proteinuria and renal dysfunction group. There was statistically difference between microalbuminuria and proteinuria group. Fasting and postprandial blood glucose were controlled better in microalbuminuria group compared with the other two groups. Abnormal lipid metabolism presented predominantly with hypertriglyceridemia and elevated low-density lipoprotein cholesterol. Conclusion:Diabetic other macro-and micro-vascular complications occurred simultaneously in patients with type 2 DN. The complications were diverse and severe in patients with severe renal dysfunction. It was emphasized that comprehensive treatment is necessary for the patients with DN. Intensive controlling of blood glucose,blood lipid and blood pressure and preventing microalbuminuria were the key for improving the prognosis,reducing complications and ameliorating the life quality of DN patients.

Clinical Status of Diabetic Cardiovascular Autonomic Neuropathy and Peripheral Polyneuropathy in Patients with Diabetes Mellitus

Prevalence of Peripheral Neuropathy in Patients with Diabetes: A Systematic Review and Meta-Analysis

The relationship between cardiac diastolic function and peripheral nerve conductive velocity in type 2 diabetic patients

Screening and Prevalence of Peripheral Neuropathy in Type 2 Diabetic Outpatients: a Randomized Multicentre Survey in 12 City Hospitals of China

Prevalence of macro- and microvascular complications in patients with type 2 diabetes and kidney disease with or without albuminuria in a single Chinese Diabetes Centre.

Association of Peripheral Neuropathy with Subclinical Left Ventricular Dysfunction in Patients with Type 2 Diabetes.

Chronic Conditions of Type 2 Diabetes in a Community:262 Case Analyses

Cardiac Autonomic Neuropathy in Diabetic Peripheral Neuropathy

Relationship Between Body Mass Index and Diabetic Cardiovascular Automonic Neuropathy, Peripheral Polyneuropathy in Patients with Type 2 Diabetes Mellitus

Relationship between hypertension and diabetic neuropathy in patients with type 2 diabetes mellitus

Cardiac Autonomic Neuropathy (Can) in Newly Diagnosed Type 2 Diabetes Mellitus Patients

Prevalence and Risk Factors of Diabetic Peripheral Neuropathy

565-P: Serum 25-Hydroxy Vitamin D Levels in Relation to Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes

Prevalence and Risk Factors of Diabetic Peripheral Neuropathy: A Population-Based Cross-Sectional Study in China.

Correlations of diabetic peripheral neuropathy with nerve conduction velocity and plasma glycosylated hemoglobin

Research Progress on the Detection of Diabetic Cardiovascular Autonomic Neuropathy

The Prevalence of Microvascular Compliations and Relative Factors in Newly Diagnosed Type 2 Diabetic Patients

Chronic Complications in Patients of Type 2 Diabetes with Diabetic Nephropathy

Determinants of Diabetic Peripheral Neuropathy and Their Clinical Significance: A Retrospective Cohort Study

Assessment of subclinical LV myocardial dysfunction in T2DM patients with diabetic peripheral neuropathy: a cardiovascular magnetic resonance study

Lower Visceral Fat is Related to Diabetic Peripheral Neuropathy